Adma Biologics reported $162.91M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adamis Pharmaceuticals ADMP:US USD 1.09M 652.25K
Adma Biologics ADMA:US USD 162.91M 16.84M
Agile Therapeutics AGRX:US USD 1.8M 543K
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Dynavax Technologies DVAX:US USD 102.61M 28.63M
Novavax NVAX:US USD 82.43M 173.87M
Takeda 4502:JP JPY 953.45B 25.94B